Trauma-induced damage-associated molecular patterns-mediated remote organ injury and immunosuppression in the acutely Ill patient

Frontiers in Immunology

Volumn 9, Issue JUN, 2018, Pages

  Vourc'h, Mickael ^a,b   Roquilly, Antoine ^a,b   Asehnoune, Karim ^a,b  

^a UNIVERSITÉ DE NANTES   (France)

^b HÔTEL DIEU   (France)

Author keywords

Critical care; Damage associated molecular pattern; Hospital acquired infection; Posttraumatic immunosuppression; Remote organ dysfunction; Transfusion

Indexed keywords

B7 ANTIGEN; CALGRANULIN A; CALGRANULIN B; CALGRANULIN C; CD86 ANTIGEN; CYTOKINE; GELATINASE B; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 72; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOCHONDRIAL DNA; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PROTEIN S 100; PROTEIN S100B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

AMPLITUDE MODULATION; BRAIN DAMAGE; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DEATH; DENDRITIC CELL; DISABILITY; DISSEMINATED INTRAVASCULAR CLOTTING; DNA TRANSCRIPTION; EXTRACELLULAR FLUID; GENE SILENCING; HEMOLYSIS; HUMAN; HYPOXIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INJURY; INJURY SCALE; LYMPHOCYTOPENIA; MEDICAL CARE; MULTIPLE ORGAN FAILURE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PLATELET AGGREGATION ASSAY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; REVIEW; SCORING SYSTEM; SEPSIS; STRESS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY; TRANSCRIPTION INITIATION; TRAUMATIC BRAIN INJURY;

EID: 85048564627     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.01330     Document Type: Review

References (138)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet (1997) 349:1498-504. doi:10.1016/S0140-6736(96)07492-2
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest (1992) 101:1644-55. doi:10.1378/chest.101.6.1644
3. Hoover L, Bochicchio GV, Napolitano LM, Joshi M, Bochicchio K, Meyer W, et al. Systemic inflammatory response syndrome and nosocomial infection in trauma. J Trauma (2006) 61:310-7. doi:10.1097/01.ta.0000229052.75460.c2
4. Bochicchio GV, Napolitano LM, Joshi M, Knorr K, Tracy JK, Ilahi O, et al. Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma (2002) 53:245-51. doi:10.1097/00005373-200208000-00010
5. Asehnoune K, Roquilly A, Abraham E. Innate immune dysfunction in trauma patients. Anesthesiology (2012) 117:411-6. doi:10.1097/ALN.0b013e31825f018d
6. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med (2011) 208:2581-90. doi:10.1084/jem.20111354
7. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis (2013) 13:260-8. doi:10.1016/S1473-3099(13)70001-X
8. Roquilly A, Mahe PJ, Seguin P, Guitton C, Floch H, Tellier AC, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA (2011) 305:1201-9. doi:10.1001/jama.2011.360
9. Harris HE, Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep (2006) 7:774-8. doi:10.1038/sj.embor.7400759
10. Manson J, Thiemermann C, Brohi K. Trauma alarmins as activators of damage-induced inflammation. Br J Surg (2012) 99(Suppl 1):12-20. doi:10.1002/bjs.7717
11. Ma KC, Schenck EJ, Pabon MA, Choi AMK. The role of danger signals in the pathogenesis and perpetuation of critical illness. Am J Respir Crit Care Med (2018) 197(3):300-9. doi:10.1164/rccm.201612-2460PP
12. Lee YL, King M, Gillespie MN, Gonzalez RP, Brevard SB, Frotan MA, et al. Blood transfusion products contain mitochondrial DNA damps: a potential effector of transfusion related acute lung injury. J Surg Res (2014) 186:509. doi:10.1016/j.jss.2013.11.280
13. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 464:104-7. doi:10.1038/nature08780
14. Gan L, Chen X, Sun T, Li Q, Zhang R, Zhang J, et al. Significance of serum mtDNA concentration in lung injury induced by hip fracture. Shock (2015) 44:52-7. doi:10.1097/SHK.0000000000000366
15. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem (2000) 46:319-23
16. Simmons JD, Lee Y-L, Mulekar S, Kuck JL, Brevard SB, Gonzalez RP, et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg (2013) 258:591-6. doi:10.1097/SLA.0b013e3182a4ea46
17. Gu X, Yao Y, Wu G, Lv T, Luo L, Song Y. The plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome. PLoS One (2013) 8:e72834. doi:10.1371/journal.pone.0072834
18. Atamaniuk J, Kopecky C, Skoupy S, Säemann MD, Weichhart T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant (2012) 27:902-5. doi:10.1093/ndt/gfr695
19. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for toll-like receptor 3. J Biol Chem (2004) 279:12542-50. doi:10.1074/jbc. M310175200
20. He Z-W, Qin Y-H, Wang Z-W, Chen Y, Shen Q, Dai S-M. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways. Mediators Inflamm (2013) 2013:1-10. doi:10.1155/2013/596716
21. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation (2008) 117:3216-26. doi:10.1161/CIRCULATIONAHA.108.769331
22. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 201:1135-43. doi:10.1084/jem.20042614
23. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, et al. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med (2006) 12:105-14. doi:10.2119/2006-00010.Yang
24. Cohen MJ, Brohi K, Calfee CS, Rahn P, Chesebro BB, Christiaans SC, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care (2009) 13:R174. doi:10.1186/cc8152
25. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol (2005) 288:L958-65. doi:10.1152/ajplung.00359.2004
26. van Zoelen MAD, Ishizaka A, Wolthuis EK, Choi G, van der Poll T, Schultz MJ. Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock (2008) 29(4):441-5. doi:10.1097/SHK.0b013e318157eddd
27. Degos V, Maze M, Vacas S, Hirsch J, Guo Y, Shen F, et al. Bone fracture exacerbates murine ischemic cerebral injury. Anesthesiology (2013) 118:1362-72. doi:10.1097/ALN.0b013e31828c23f8
28. Sodhi CP, Jia H, Yamaguchi Y, Lu P, Good M, Egan C, et al. Intestinal epithelial TLR-4 activation is required for the development of acute lung injury after trauma/hemorrhagic shock via the release of HMGB1 from the gut. J Immunol (2015) 194:4931-9. doi:10.4049/jimmunol.1402490
29. Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 14:1315-35. doi:10.1089/ars.2010.3356
30. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med (2012) 209:1519-28. doi:10.1084/jem.20120189
31. Gaston JSH. Heat shock proteins and innate immunity. Clin Exp Immunol (2002) 127:1-3. doi:10.1046/j.1365-2249.2002.01759.x
32. Xu Q. Role of heat shock proteins in atherosclerosis. Arterioscler Thromb Vasc Biol (2002) 22:1547-59. doi:10.1161/01.ATV.0000029720.59649.50
33. Rea IM, McNerlan S, Pockley AG. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp Gerontol (2001) 36:341-52. doi:10.1016/S0531-5565(00)00215-1
34. Timmermans K, Kox M, Vaneker M, van den Berg M, John A, van Laarhoven A, et al. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med (2016) 42:551-61. doi:10.1007/s00134-015-4205-3
35. Aneja R, Odoms K, Dunsmore K, Shanley TP, Wong HR. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol (2006) 177:7184-92. doi:10.4049/jimmunol.177.10.7184
36. Pockley AG, Shepherd J, Corton JM. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest (1998) 27:367-77. doi:10.3109/08820139809022710
37. Pittet J-F, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC. Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma (2002) 52:611-7; discussion 617
38. Murphy TJ, Paterson HM, Mannick JA, Lederer JA. Injury, sepsis, and the regulation of Toll-like receptor responses. J Leukoc Biol (2004) 75:400-7. doi:10.1189/jlb.0503233
39. Wang Y, Kelly CG, Singh M, McGowan EG, Carrara AS, Bergmeier LA, et al. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J Immunol (2002) 169:2422-9. doi:10.4049/jimmunol.169.5.2422
40. Singh-Jasuja H, Scherer HU, Hilf N, Arnold-Schild D, Rammensee H-G, Toes REM, et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol (2000) 30:2211. doi:10.1002/1521-4141(2000)30:8<2211::AID-IMMU2211>3.0.CO;2-0
41. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol (2007) 81:28-37. doi:10.1189/jlb.0306170
42. Roth J, Teigelkamp S, Wilke M, Grün L, Tümmler B, Sorg C. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology (1992) 186:304-14. doi:10.1016/S0171-2985(11)80259-7
43. Vogl T, Pröpper C, Hartmann M, Strey A, Strupat K, van den Bos C, et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem (1999) 274:25291-6. doi:10.1074/jbc.274.36.25291
44. Zwadlo G, Brüggen J, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol (1988) 72:510-5
45. Austermann J, Friesenhagen J, Fassl SK, Petersen B, Ortkras T, Burgmann J, et al. Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep (2014) 9:2112-23. doi:10.1016/j.celrep.2014.11.020
46. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery (1999) 45:477-83. doi:10.1097/00006123-199909000-00012
47. Goyal A, Failla MD, Niyonkuru C, Amin K, Fabio A, Berger RP, et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J Neurotrauma (2013) 30:946-57. doi:10.1089/neu.2012.2579
48. Vos PE, Jacobs B, Andriessen TMJC, Lamers KJB, Borm GF, Beems T, et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology (2010) 75:1786-93. doi:10.1212/WNL.0b013e3181fd62d2
49. Murphy MB, Medvedev AE. Long noncoding RNAs as regulators of Toll-like receptor signaling and innate immunity. J Leukoc Biol (2016) 99:839-50. doi:10.1189/jlb.2RU1215-575R
50. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 34:637-50. doi:10.1016/j.immuni.2011.05.006
51. Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell (2006) 125:943-55. doi:10.1016/j.cell.2006.03.047
52. Adib-Conquy M, Asehnoune K, Moine P, Cavaillon JM. Long-term-impaired expression of nuclear factor-kappa B and I kappa B alpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol (2001) 70:30-8. doi:10.1189/jlb.70.1.30
53. Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol (2010) 28:321-42. doi:10.1146/annurev-immunol-030409-101311
54. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity (2012) 36:401-14. doi:10.1016/j.immuni.2012.01.009
55. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem (2004) 279:7370-7. doi:10.1074/jbc. M306793200
56. Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery (1999) 126:389-92. doi:10.1016/S0039-6060(99)70182-0
57. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science (1999) 285:248-51. doi:10.1126/science.285.5425.248
58. Yang H, Wang H, Ju Z, Ragab AA, Lundbäck P, Long W, et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med (2015) 212:5-14. doi:10.1084/jem.20141318
59. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-production in human monocytes. J Immunol (2008) 180:5067-74. doi:10.4049/jimmunol.180.7.5067
60. Tian J, Avalos AM, Mao S-Y, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8:487-96. doi:10.1038/ni0707-780b
61. Coveney AP, Wang W, Kelly J, Liu JH, Blankson S, Wu QD, et al. Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4-and TLR2-mediated signal pathways. Sci Rep (2015) 5:13694. doi:10.1038/srep13694
62. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology (2008) 213:701-13. doi:10.1016/j.imbio.2008.07.008
63. Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther (2017) 177:81-95. doi:10.1016/j.pharmthera.2017.02.043
64. Weber DJ, Gracon ASA, Ripsch MS, Fisher AJ, Cheon BM, Pandya PH, et al. The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation. Sci Transl Med (2014) 6:252ra124. doi:10.1126/scitranslmed.3009443
65. van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis (2008) 11:91-9. doi:10.1007/s10456-008-9093-5
66. Vega-Ramos J, Roquilly A, Zhan Y, Young LJ, Mintern JD, Villadangos JA. Inflammation conditions mature dendritic cells to retain the capacity to present new antigens but with altered cytokine secretion function. J Immunol (2014) 193:3851-9. doi:10.4049/jimmunol.1303215
67. Hauser CJ, Sursal T, Rodriguez EK, Appleton PT, Zhang Q, Itagaki K. Mitochondrial damage associated molecular patterns from femoral reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase. J Orthop Trauma (2010) 24:534-8. doi:10.1097/BOT.0b013e3181ec4991
68. Wenceslau CF, Szasz T, McCarthy CG, Baban B, NeSmith E, Webb RC. Mitochondrial N-formyl peptides cause airway contraction and lung neutrophil infiltration via formyl peptide receptor activation. Pulm Pharmacol Ther (2016) 37:49-56. doi:10.1016/j.pupt.2016.02.005
69. Huebener P, Pradere J-P, Hernandez C, Gwak G-Y, Caviglia JM, Mu X, et al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2015) 125:539-50. doi:10.1172/JCI76887
70. Huang H, Tohme S, Al-Khafaji AB, Tai S, Loughran P, Chen L, et al. Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury. Hepatology (2015) 62:600-14. doi:10.1002/hep.27841
71. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CCM, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science (2010) 330:362-6. doi:10.1126/science.1195491
72. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science (2006) 314:1792-5. doi:10.1126/science.1132559
73. Wenceslau CF, McCarthy CG, Szasz T, Goulopoulou S, Webb RC. Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome. Am J Physiol Heart Circ Physiol (2015) 308:H768-77. doi:10.1152/ajpheart.00779.2014
74. Hadass O, Tomlinson BN, Gooyit M, Chen S, Purdy JJ, Walker JM, et al. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One (2013) 8:e76904. doi:10.1371/journal.pone.0076904
75. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med (1999) 5:1249-55. doi:10.1038/15200
76. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger C-J, Arnold B, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol (2005) 61:1-9. doi:10.1111/j.0300-9475.2005.01534.x
77. Han J, Zhong J, Wei W, Wang Y, Huang Y, Yang P, et al. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes (2008) 57:2118-27. doi:10.2337/db07-1499
78. Flohé SB, Brüggemann J, Lendemans S, Nikulina M, MeierhoffG, Flohé S, et al. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol (2003) 170:2340-8. doi:10.4049/jimmunol.170.5.2340
79. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol (2002) 2:185-94. doi:10.1038/nri749
80. Julian MW, Shao G, Bao S, Knoell DL, Papenfuss TL, VanGundy ZC, et al. Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol (2012) 189:433-43. doi:10.4049/jimmunol.1101375
81. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med (2005) 202:1131-9. doi:10.1084/jem.20050914
82. Marriott I, Inscho EW, Bost KL. Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells. Cell Immunol (1999) 195:147-56. doi:10.1006/cimm.1999.1531
83. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 430:213-8. doi:10.1038/nature02664
84. Roquilly A, McWilliam HEG, Jacqueline C, Tian Z, Cinotti R, Rimbert M, et al. Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity (2017) 47:135-47.e5. doi:10.1016/j.immuni.2017.06.021
85. Adib-Conquy M, Moine P, Asehnoune K, Edouard A, Espevik T, Miyake K, et al. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med (2003) 168:158-64. doi:10.1164/rccm.200209-1077OC
86. Roquilly A, Braudeau C, Cinotti R, Dumonte E, Motreul R, Josien R, et al. Impaired blood dendritic cell numbers and functions after aneurysmal subarachnoid hemorrhage. PLoS One (2013) 8:e71639. doi:10.1371/journal.pone.0071639
87. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature (2007) 447:972-8. doi:10.1038/nature05836
88. Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol (2012) 8:401-10. doi:10.1038/nrneurol.2012.98
89. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke (2009) 40:2849-58. doi:10.1161/STROKEAHA.109.549618
90. Urra X, Cervera A, Obach V, Climent N, Planas AM, Chamorro A. Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke (2009) 40:1262-8. doi:10.1161/STROKEAHA.108.532085
91. Roquilly A, David G, Cinotti R, Vourc'h M, Morin H, Rozec B, et al. Role of IL-12 in overcoming the low responsiveness of NK cells to missing self after traumatic brain injury. Clin Immunol (2017) 177:87-94. doi:10.1016/j.clim.2015.08.006
92. Murphy T, Paterson H, Rogers S, Mannick JA, Lederer JA. Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann Surg (2003) 238:401-10. doi:10.1097/01.sla.0000086661.45300.14
93. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg (1995) 222:482-92. doi:10.1097/00000658-199522240-00006
94. Hug A, Dalpke A, Wieczorek N, Giese T, Lorenz A, Auffarth G, et al. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke (2009) 40:3226-32. doi:10.1161/STROKEAHA.109.557967
95. Liesz A, Rüger H, Purrucker J, Zorn M, Dalpke A, Möhlenbruch M, et al. Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases. PLoS One (2013) 8:e74839. doi:10.1371/journal.pone.0074839
96. Mracsko E, Liesz A, Karcher S, Zorn M, Bari F, Veltkamp R. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav Immun (2014) 41:200-9. doi:10.1016/j.bbi.2014.05.015
97. Liesz A, Dalpke A, Mracsko E, Antoine DJ, Roth S, Zhou W, et al. DAMP signaling is a key pathway inducing immune modulation after brain injury. J Neurosci (2015) 35:583-98. doi:10.1523/JNEUROSCI.2439-14.2015
98. Patel N, Wu W, Mishra PK, Chen F, Millman A, Csóka B, et al. A2B adenosine receptor induces protective antihelminth type 2 immune responses. Cell Host Microbe (2014) 15:339-50. doi:10.1016/j.chom.2014.02.001
99. Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, Feoktistov I. Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol (2004) 172:7726-33. doi:10.4049/jimmunol.172.12.7726
100. Yang G, Wan M, Zhang Y, Sun L, Sun R, Hu D, et al. Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice. Immunology (2010) 131:501-12. doi:10.1111/j.1365-2567.2010.03322.x
101. Noble A, Mehta H, Lovell A, Papaioannou E, Fairbanks L. IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells. Eur J Immunol (2016) 46:1438-48. doi:10.1002/eji.201545939
102. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med (2007) 204:1257-65. doi:10.1084/jem.20062512
103. Boer MC, van Meijgaarden KE, Bastid J, OttenhoffTHM, Joosten SA. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells. Eur J Immunol (2013) 43:1925-32. doi:10.1002/eji.201243286
104. Li P, Gao Y, Cao J, Wang W, Chen Y, Zhang G, et al. CD39+ regulatory T cells attenuate allergic airway inflammation. Clin Exp Allergy (2015) 45:1126-37. doi:10.1111/cea.12521
105. Karam O, Tucci M, Toledano BJ, Robitaille N, Cousineau J, Thibault L, et al. Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion (2009) 49:2326-34. doi:10.1111/j.1537-2995.2009.02319.x
106. Pham HP, Shaz BH. Update on massive transfusion. Br J Anaesth (2013) 111(Suppl 1):i71-82. doi:10.1093/bja/aet376
107. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg (2002) 68:566-72
108. Chelemer SB, Prato BS, Cox PM Jr, O'Connor GT, Morton JR. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg (2001) 73:138-42. doi:10.1016/S0003-4975(01)03308-2
109. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood (1999) 93:1770-7
110. MacConmara MP, Maung AA, Fujimi S, McKenna AM, Delisle A, Lapchak PH, et al. Increased CD4+ CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg (2006) 244:514-23. doi:10.1097/01.sla.0000239031.06906.1f
111. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, et al. Duration of red-cell storage and complications after cardiac surgery. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 358:1229-39. doi:10.1056/NEJMoa070403
112. Cooper DJ, McQuilten ZK, Nichol A, Ady B, Aubron C, Bailey M, et al. Age of red cells for transfusion and outcomes in critically ill adults. N Engl J Med (2017) 377(19):1858-67. doi:10.1056/NEJMoa1707572
113. Lacroix J, Hebert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, et al. Age of transfused blood in critically ill adults. N Engl J Med (2015) 372:1410-8. doi:10.1056/NEJMoa1500704
114. European Directorate for the Quality of Medicines & HealthCare. Guide for the Preparation, Use and Quality Assurance of Blood Component. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (2007)
115. Mendonça R, Silveira AAA, Conran N. Red cell DAMPs and inflammation. Inflamm Res (2016) 65:665-78. doi:10.1007/s00011-016-0955-9
116. Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, et al. Characterization of heme as activator of toll-like receptor 4. J Biol Chem (2007) 282:20221-9. doi:10.1074/jbc. M610737200
117. Wegiel B, Hauser CJ, Otterbein LE. Heme as a danger molecule in pathogen recognition. Free Radic Biol Med (2015) 89:651-61. doi:10.1016/j.freeradbiomed.2015.08.020
118. Dzieciatkowska M, Silliman CC, Moore EE, Kelher MR, Banerjee A, Land KJ, et al. Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction. Vox Sang (2013) 105:210-8. doi:10.1111/vox.12042
119. Du M, Martin A, Hays F, Johnson J, Farjo RA, Farjo KM. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Mol Vis (2017) 23:185-97
120. Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta (2014) 1843:2563-82. doi:10.1016/j.bbamcr.2014.05.014
121. Lott JM, Sumpter TL, Turnquist HR. New dog and new tricks: evolving roles for IL-33 in type 2 immunity. J Leukoc Biol (2015) 97:1037-48. doi:10.1189/jlb.3RI1214-595R
122. Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity (2015) 42:1005-19. doi:10.1016/j.immuni.2015.06.006
123. Sprague RS, Ellsworth ML. Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication. Microcirculation (2012) 19:430-9. doi:10.1111/j.1549-8719.2011.00158.x
124. Jheng H-F, Tsai P-J, Chuang Y-L, Shen Y-T, Tai T-A, Chen W-C, et al. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy. Dis Model Mech (2015) 8:1311-21. doi:10.1242/dmm.019398
125. Bertheloot D, Latz E. HMGB1, IL-1a, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol (2017) 14:43-64. doi:10.1038/cmi.2016.34
126. Rendy L, Sapan HB, Kalesaran LTB. Multiple organ dysfunction syndrome (MODS) prediction score in multi-trauma patients. Int J Surg Open (2017) 8:1-6. doi:10.1016/j.ijso.2017.05.003
127. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of trauma deaths: a reassessment. J Trauma (1995) 38:185-93. doi:10.1097/00005373-199502000-00006
128. Peltz ED, Moore EE, Eckels PC, Damle SS, Tsuruta Y, Johnson JL, et al. HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock (2009) 32:17-22. doi:10.1097/SHK.0b013e3181997173
129. Wang X-W, Karki A, Zhao X-J, Xiang X-Y, Lu Z-Q. High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: a prospective cohort study. J Cardiothorac Surg (2014) 9:133. doi:10.1186/s13019-014-0133-5
130. Deng Y, Yang Z, Gao Y, Xu H, Zheng B, Jiang M, et al. Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1. PLoS One (2013) 8:e64375. doi:10.1371/journal.pone.0064375
131. Kalanuria A, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care (2014) 18:208. doi:10.1186/cc13775
132. de Lange DW, Bonten MJM. Can we predict septic shock in patients with hospital-acquired pneumonia? Crit Care (2005) 9:640-1. doi:10.1186/cc3919
133. Kesinger MR, Kumar RG, Wagner AK, Puyana JC, Peitzman AP, Billiar TR, et al. Hospital-acquired pneumonia is an independent predictor of poor global outcome in severe traumatic brain injury up to 5 years after discharge. J Trauma Acute Care Surg (2015) 78:396-402. doi:10.1097/TA.0000000000000526
134. Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care (2014) 2:67. doi:10.1186/s40560-014-0065-0
135. Kim J-E, Lee N, Gu J-Y, Yoo HJ, Kim HK. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation. Thromb Res (2015) 135:1064-9. doi:10.1016/j.thromres.2015.03.014
136. Altincicek B, Stötzel S, Wygrecka M, Preissner KT, Vilcinskas A. Host-derived extracellular nucleic acids enhance innate immune responses, induce coagulation, and prolong survival upon infection in insects. J Immunol (2008) 181:2705-12. doi:10.4049/jimmunol.181.4.2705
137. Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost (2011) 9:1795-803. doi:10.1111/j.1538-7836.2011.04422.x
138. Ito T, Kawahara K, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost (2006) 5:109-16. doi:10.1111/j.1538-7836.2006.02255.x